Document:

<PAGE>
                                                                 EXHIBIT 10.2.12

         AMENDMENT NO. 1 TO (I) LOAN AND SECURITY AGREEMENT DATED FEBRUARY 4,
2004, BETWEEN DELPHAX TECHNOLOGIES INC. AND LASALLE BUSINESS CREDIT, LLC, AND
(II) CREDIT AGREEMENT DATED FEBRUARY 4, 2004 BETWEEN DELPHAX TECHNOLOGIES CANADA
LIMITED AND ABN AMRO BANK, N.V., CANADA BRANCH

         This Amendment No. 1 (this "Amendment"), made and entered into as of
February 24, 2004 is by and between DELPHAX TECHNOLOGIES INC., a Minnesota
Corporation (the "U.S. BORROWER"), LASALLE BUSINESS CREDIT, LLC, a Delaware
limited liability company (the "U.S. LENDER"), DELPHAX TECHNOLOGIES CANADA
LIMITED, a corporation organized under the laws of the province of Ontario (the
"CANADIAN BORROWER" and collectively with the U.S. Borrower, the "BORROWERS"),
and ABN AMRO BANK, N.V., CANADA BRANCH, a Canadian branch of a Netherlands bank
(the "CANADIAN LENDER," and collectively with U.S. Lender, the "LENDERS").

                                     RECITAL

         A. The U.S. Borrower and the U.S. Lender have entered into that certain
Loan and Security Agreement dated as of February 4, 2004 (the "U.S. LOAN
AGREEMENT"). The Canadian Borrower and the Canadian Lender have entered into
that certain Credit Agreement dated as of February 4, 2004 (the "CANADIAN LOAN
Agreement" and collectively with the U.S. Loan Agreement, the "LOAN
AGREEMENTS").

         B. The Borrowers and the Lenders now desire to amend the Loan
Agreements as provided herein, subject to the terms and conditions hereinafter
set forth.

         NOW, THEREFORE, in consideration of the foregoing recitals, the mutual
covenants and agreements set forth herein and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties hereto hereby agree as follows:

         1. AMENDMENT TO U.S. LOAN AGREEMENT. The U.S. Borrower and the U.S.
Lender agree that paragraph 14(a) of the U.S. Loan Agreement is hereby amended
and restated in its entirety to read as follows:

         (a)      TANGIBLE NET WORTH

         Borrower's Tangible Net Worth shall not at any time be less than the
         Minimum Tangible Net Worth; "MINIMUM TANGIBLE NET WORTH" being defined
         for purposes of this subsection as (i) 90% of $15,817,000 at all times
         from the date hereof to and including September 29, 2004, (ii)
         $16,500,000 on September 30, 2004, and (iii) thereafter, (A) from the
         first day of each Fiscal Year of Borrower through the day prior to the
         last day of such Fiscal Year of Borrower, 90% of Borrower's Tangible
         Net Worth on the last day of the immediately preceding Fiscal Year of
         Borrower and (B) on the last day of each Fiscal Year of Borrower, 110%
         of Borrower's Tangible Net Worth on the last day of the immediately
         preceding Fiscal Year of Borrower, in each case as reflected on
         Borrower's audited year end financial statement; and "TANGIBLE NET
         WORTH" being defined for purposes of this subsection as Borrower's
         consolidated shareholders' equity

                                     - 1 -

<PAGE>

         (including retained earnings) less the book value of intangible assets
         as determined solely by Lender on a consistent basis plus the amount of
         any LIFO reserve plus the amount of Subordinated Debt less prepaid
         expenses, amounts due from officers, employees and affiliates, all as
         determined on a consolidated basis for the Borrower and its
         Subsidiaries and without duplication under generally accepted
         accounting principles applied on a basis consistent with the financial
         statement dated September 30, 2003 except as set forth herein.

         2. AMENDMENT TO CANADIAN LOAN AGREEMENT. The Canadian Borrower and the
Canadian Lender agree that paragraph 1(a) of the Canadian Loan Agreement is
hereby amended by amending the definition of "U.S. Loan and Security Agreement"
contained therein to read in its entirety as follows:

         "U.S. Loan and Security Agreement" shall mean that certain loan and
         security agreement dated February 4, 2004 between U.S. Lender and the
         Guarantor, as amended by that certain Amendment No. 1 dated as of
         February 24, 2004, and as the same may be further amended, restated,
         supplemented or otherwise modified from time to time.

         3. CONDITIONS PRECEDENT. The amendments contained in this Amendment
shall become effective upon delivery by Borrowers to the Lenders of, and
compliance by relevant Borrowers with, the following:

         (a) This Amendment, duly executed by each of Borrowers and each of the
         Lenders.

         (b) The U.S. Borrower shall have paid to the U.S. Lender a
         nonrefundable amendment fee of $75,000.

         4. REPRESENTATIONS AND WARRANTIES. Each Borrower hereby represents and
warrants to the Lenders as follows:

         (a) that on and as of the date hereof and after giving effect to this
         Amendment there will exist no Default or Event of Default (as defined
         in the U.S. Loan Agreement and the Canadian Loan Agreement, as
         applicable) under the Loan Agreements as amended by this Amendment on
         such date which has not been waived by relevant Lender.

         (b) each Borrower has the power and legal right and authority to enter
         into this Amendment and any other document or instrument to be executed
         by such Borrower in connection with this Amendment (collectively, the
         Amendment Documents) and has duly authorized as appropriate the
         execution and delivery of the relevant Amendment Documents by proper
         corporate action.

                                      -2-

<PAGE>

         5. RATIFICATION OF LOAN AGREEMENTS. Except as expressly amended hereby,
the Loan Agreements hereby are ratified and confirmed by the parties hereto and
remain in full force and effect in accordance with the terms thereof.

         6. SUBORDINATED CREDITOR CONSENT. The U. S. Borrower shall (a)
undertake its best efforts to, within 30 days of the date of this Amendment,
deliver to the U.S. Lender the Acknowledgment and Agreement of Subordinated
Creditor (collectively, the "Subordinated Creditor Consent") set forth at the
end of this Amendment, duly executed by Tate Capital Partners Fund, LLC (the
"Subordinated Creditor") and (b) undertake its best efforts to cause the
Subordinated Creditor to not require the U.S. Borrower to execute and deliver
any other amendments to its loan documents with the Subordinated Creditors or to
pay any fees to the Subordinated Creditor as a condition to executing its
Subordinated Creditor Consent.

         7. GENERAL RELEASE. Each Borrower hereby absolutely and unconditionally
releases and forever discharges each Lender, and any and all participants,
parent corporations, subsidiary corporations, affiliated corporations, insurers,
indemnitors, successors and assigns thereof, together with all of the present
and former directors, officers, agents and employees of any of the foregoing,
from any and all claims, demands or causes of action of any kind, nature or
description, whether arising in law or equity or upon contract or tort or under
any state or federal law or otherwise, which any Borrower has had, now has or
has made claim to have against any such person for or by reason of any act,
omission, matter, cause or thing whatsoever arising from the beginning of time
to and including the date of this Amendment, whether such claims, demands and
causes of action are matured or unmatured or known or unknown.

         8. REAFFIRMATION OF GUARANTIES. Each Borrower, in its capacity as a
guarantor of the indebtedness of the other Borrower to the U.S. Lender or the
Canadian Lender, as applicable, pursuant to the separate Guaranty or Guarantee
dated as of February 4, 2004 (each, a "Guaranty"), hereby (i) consents to the
terms of the Amendment of the other Borrower's Loan Agreement as set forth in
the Amendment; (iii) reaffirms its obligations to the applicable Lender pursuant
to the terms of its Guaranty; and (iv) acknowledges that the applicable Lender
may amend, restate, extend, renew or otherwise modify its Loan Agreement with
the other Borrower and any indebtedness or agreement of the other Borrower, or
enter into any agreement or extend additional or other credit accommodations to
the other Borrower, without notifying or obtaining the consent of the
undersigned and without impairing the liability of the such Borrower under its
Guaranty.

               [Remainder of this page intentionally left blank.]

                                      -3-

<PAGE>

         IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be
duly executed as of the date first written above.

                               DELPHAX TECHNOLOGIES INC.

                               By:   /s/ Robert M. Barniskis
                                   ---------------------------------------------
                               Title: Vice President and Chief Financial Officer

                               DELPHAX TECHNOLOGIES CANADA LIMITED

                               By:  /s/ Robert M. Barniskis
                                   ---------------------------------------------
                               Title: Chief Financial Officer

                               LASALLE BUSINESS CREDIT, LLC

                               By:  /s/ Bradley E. Handrich
                                   ---------------------------------------------
                               Title: Assistant Vice President

                               ABN AMRO BANK N.V., CANADA BRANCH

                               By:  /s/ Darcy Mack
                                   ---------------------------------------------
                               Title: Vice President

                                      -4-

<PAGE>

              ACKNOWLEDGMENT AND AGREEMENT OF SUBORDINATED CREDITOR

         The undersigned, a subordinated creditor of Delphax Technologies Inc.
("U.S. Borrower") pursuant to a Subordination Agreement dated as of February 4,
2004 (the "Subordination Agreement") between the undersigned and LaSalle
Business Credit, LLC (the "Lender") hereby (i) acknowledges receipt of the
foregoing Amendment; (ii) consents to the terms and execution thereof; and (iii)
reaffirms its obligations to the Lender pursuant to the terms of its
Subordination Agreement.

                                        TATE CAPITAL PARTNERS FUND, LLC

                                        By:  /s/ Frank R. McEvoy
                                            ------------------------------------
                                        Title: General Partner

                                      -5-exv4w5

 

Exhibit 4.5

ILEX ONCOLOGY, INC.

1995 STOCK OPTION PLAN

 

 

TABLE OF CONTENTS

	 	 	 	 	 	 	 	 	 
	 	1.	 	 	Purposes of the Plan
	 	 	1	 
	 	2.	 	 	Definitions
	 	 	1	 
	 	3.	 	 	Scope of the Plan
	 	 	3	 
	 	4.	 	 	Administration
	 	 	3	 
	 	5.	 	 	Stock Subject to the Program; Adjustments Upon Changes in Capitalization
	 	 	4	 
	 	6.	 	 	Stock Options
	 	 	5	 
	 	7.	 	 	General Provisions
	 	 	9	 
	 	8.	 	 	Compliance with Other Laws and Regulations
	 	 	10	 
	 	9.	 	 	Effective Date
	 	 	11	 
	 	10.	 	 	Amendment or Termination of Program
	 	 	11	 
	 	11.	 	 	Applicable Law
	 	 	11	 

 

 

AMENDED AND RESTATED

ILEX ONCOLOGY, INC.

1995 STOCK OPTION PLAN

1. Purposes of the Plan

     1.1. The purposes of the ILEX Oncology, Inc. 1995 Stock Option Plan are
(a) to assist ILEX Oncology, Inc. in attracting and retaining in the employ of
the Company and any Subsidiaries individuals of outstanding competence, and (b)
to provide performance incentives for officers, executives, key employees of
and advisors and independent consultants to the Company and any Subsidiaries.

2. Definitions

     Unless otherwise required by the context, the terms used in this Plan
shall have the meanings indicated in this Section 2. Except where context
indicates otherwise, the use of the masculine shall include the feminine, and
the use of the singular shall include the plural.

     “Beneficiary”: As applied to a participant in the Plan, a person or
entity (including a trust or the estate of the participant) designated in
writing by the participant on such forms as the Committee may prescribe to whom
an Option may pass in the event of the death of the participant. If, at the
death of a participant, there shall not be any living person or entity in
existence so designated, the term “Beneficiary” shall mean the legal
representative of the participant’s estate.

     “Board or Board of Directors”: The Board of Directors of the Company.

     “Committee”: The Option Committee of the Board of Directors or such other
committee as may be designated by the Board of Directors under Section 4.1 to
administer the Plan.

     “Common Stock”: The common stock of the Company, $.01 par value, or such
other class of shares or other securities as may be applicable in accordance
with Sections 5.1 and 5.2.

     “Company”: ILEX Oncology, Inc., a Delaware corporation, its successors
and assigns.

     “Consultant”: A non-employee director on the Company’s Board of
Directors, or an advisor or independent consultant to the Company who, in the
opinion of the Committee, is in a position to make significant contributions to
the Company or a Subsidiary.

     “Incentive Stock Option”: A form of stock option which, by specific
provision of the Internal Revenue Code of 1986, as amended, is not subject to
federal income tax at the time of its grant or exercise and is issuable only to
employees of the corporation granting the option or a parent or subsidiary of
such corporation.

1

 

     “Key Employee”: An employee of the Company or of a Subsidiary regularly
employed on a full-time basis, including an officer or director if he is such
an employee, who, in the opinion of the Committee, is in a position to make
significant contributions to the Company or a Subsidiary.

     “Market Value”: As applied to a specific date and unless otherwise
specifically defined in the text of the Plan, (i) the closing sale price of the
Common Stock for such date as reported on the National Association of
Securities Dealers Automated Quotation (“NASDAQ”) system (or, if no such sales
were reported for such date, on the next preceding date for which such sales
were reported), or (ii) if the price of Common Stock is not reported on the
NASDAQ system or any other national exchange, the fair market value as
determined in good faith by the Committee.

     “Option” or “Stock Option”: An option to purchase shares of Common Stock
granted under Section 6.1.

     “Optionee”: A Key Employee or Consultant who has received an Option or
Options under the Plan.

     “Permanent Disability”: The permanent incapacity of a participant in the
Plan to perform the usual duties of his employment by reason of physical or
mental impairment. For this purpose, “Permanent Disability” shall be deemed to
exist if Optionee is unable by reason of material physical or mental impairment
to perform the duties of his regular position with the Company and is not
expected to recover from his disability within a period of six months from the
commencement of the disability. If at any time Optionee has claimed to be
permanently disabled, a physician acceptable to both Optionee and the Committee
(which acceptances shall not be unreasonably withheld) shall be retained by the
Committee and shall examine Optionee. Optionee shall cooperate fully with the
physician. If the physician determines that Optionee is permanently disabled,
the physician shall deliver to the Committee a certificate certifying both that
Optionee is permanently disabled and the date upon which the condition of
permanent disability commenced. The determination of the physician shall be
conclusive. For purposes of Options that are Incentive Stock Options,
Permanent Disability shall be interpreted in a manner that is consistent with
Internal Revenue Code Section 22(e)(3).

     “Plan”: The ILEX Oncology, Inc. 1995 Stock Option Plan, as amended from
time to time.

     “Restricted Stock”: Shares of Common Stock issued or transferred subject
to restrictions precluding a sale or other disposition for a period of time
(other than as specifically may be permitted) and requiring, as a condition to
retention, compliance with any other terms and conditions that may be imposed
by the Committee.

     “Retirement”: The termination of a participant’s employment with the
Company and its Subsidiaries due to and consistent with the retirement policies
of the Company and its Subsidiaries.

2

 

“Rule 16b-3”: As applied on a specific date, Rule 16b-3 of the General
Rules and Regulations under the Securities Exchange Act of 1934 as then in
effect or any other provision that may have replaced such Rule and be then in
effect.

     “Subsidiary”: Any corporation or other form of business association of
which shares (or other ownership interests) having more than 50% of the voting
power are owned or controlled, directly or indirectly, by the Company.

     “Supplement”: Rules of general application consistent with the Plan
adopted by the Committee as a supplement thereto for the administration or
implementation of the Plan or a portion thereof.

3. Scope of the Plan

     The Plan shall apply to the Company and to any Subsidiaries which have not
been specifically excluded by the Board of Directors.

4. Administration

     4.1. The Plan shall be administered by a committee of two or more persons
selected by the Board of Directors from its own membership who are not
employees of the Company, which shall be the Option Committee of the Board of
Directors unless another committee of the Board shall be designated by the
Board.

     4.2. The Committee shall have full power to interpret and administer the
Plan and full authority to act in determining who shall be participants in the
Plan, the number of Options to be granted to each participant, and the
conditions, form, manner, time and terms of payment under such Options. The
interpretation by the Committee of the terms and provisions of the Plan and the
administration thereof, and all action taken by the Committee, shall be final,
binding and conclusive on the Company, its stockholders, Subsidiaries, all
participants and employees, and upon their respective Beneficiaries, successors
and assigns, and upon all other persons claiming under or through any of them.

     4.3. The Committee may adopt such rules, regulations and Supplements, not
inconsistent with the provisions of the Plan, as it deems necessary (a) to
determine participation in the Plan, the amount to be granted to each
participant and the conditions, form, manner, time and terms of payment under
such Options and (b) to administer the Plan, and may amend or revoke any such
rule, regulation or Supplement.

     4.4. No member or former member of the Committee or of the Company’s Board
of Directors shall be liable for any action or determination made in good faith
with respect to the Plan or any Option granted hereunder. To the maximum
extent permitted by applicable law, each member or former member of the
Committee or of the Company’s Board of Directors shall be indemnified and held
harmless by the Company against any cost or expense (including reasonable fees
and expenses of counsel) or liability (including any sum paid in settlement of
a claim with the approval of the Company), arising out of any act or omission
to act in connection

3

 

with the Plan, unless arising out of such member’s or former member’s own
fraud or bad faith. Such indemnification shall be in addition to any rights of
indemnification the members or former members may have as directors or under
the by-laws of the Company.

5. Stock Subject to the Program; Adjustments Upon Changes in Capitalization

     5.1. The aggregate number of shares of Common Stock which may be issued or
transferred under the Plan shall not exceed 1,800,000, subject to Sections 5.2
and 6.2(l). Such shares may be authorized but unissued shares of Common Stock,
shares of treasury stock or shares purchased for the Plan under Section 7.5.

     5.2. The existence of outstanding Options shall not affect in any way the
right or power of the Company or its stockholders to make or authorize any or
all adjustments, recapitalizations, reorganizations or other changes in the
Company’s capital structure or its business, or any merger or consolidation of
the Company, or any issue of bonds, debentures, preferred or prior preference
stock ahead of or affecting the Common Stock or the rights of the Common Stock,
or the dissolution or liquidation of the Company, or any sale or transfer of
all or any part of its assets or business, or any other corporate act or
proceeding, whether of a similar character or otherwise.

     If the Company shall effect a subdivision or consolidation of shares or
other capital readjustment, the payment of a stock dividend, or other increase
or reduction of the number of shares of the Common Stock outstanding, without
receiving compensation for it in money, services or property, then (a) the
number, class and per share price of shares of stock subject to outstanding
Options under this Plan shall be appropriately adjusted in a manner as to
entitle an optionee to receive upon exercise of an Option, for the same
aggregate cash consideration, the same total number and class or classes of
shares as he would have received had he exercised his Option in full
immediately prior to the event requiring the adjustment; and (b) the number and
class of shares then reserved for issuance under this Plan shall be adjusted by
substituting for the total number and class of shares of stock then reserved
for the number and class or classes of shares of stock that would have been
received by the owner of an equal number of outstanding shares of Common Stock
as the result of the event requiring the adjustment.

     If the Company merges or consolidates with another corporation, whether or
not the Company is a surviving corporation, or if the Company is liquidated or
sells or otherwise disposes of substantially all its assets while unexercised
Options remain outstanding under the Plan, (a) subject to the provisions of
clause (c) below, after the effective date of the merger, consolidation,
liquidation, sale or other disposition, as the case may be, each holder of an
outstanding Option shall be entitled, upon exercise of an Option, to receive,
in lieu of shares of Common Stock, the number and class or classes of shares of
stock or other securities or property to which the holder would have been
entitled if, immediately prior to the merger, consolidation, liquidation, sale
or other disposition, the holder had been the holder of record of a number of
shares of Common Stock equal to the number of shares as to which the Option may
be exercised.

     Except as expressly provided before in this Plan, the issue by the Company
of shares of stock of any class, or securities convertible into shares of stock
of any class, for cash or property, or for labor or services either upon direct sale or upon the exercise of
rights or warrants to

4

 

subscribe for shares, or upon conversion of shares or
obligations of the Company convertible into shares or other securities, shall
not affect, and no adjustment by reason of it shall be made with respect to,
the number or price of shares of Common Stock then subject to outstanding
Options.

6. Stock Options

	 	6.1.	 	Grants of Options.
	 
	 	(a)	 	The form or forms of Options and the number of shares of
Common Stock to be made subject to such Options shall be determined
by the Committee. Any or all Options granted to Key Employees under
the Plan may be in the form of Incentive Stock Options, as
determined by the Committee. Incentive Stock Options may be granted
by the Committee in substitution for any Stock Option heretofore or
hereafter granted to Key Employees under the Plan or under any prior
stock option plans of the Company, and such substitution shall not
be deemed the grant of a new or additional Option for any purpose
under the Plan or otherwise, to the extent permitted by applicable
law.
	 
	 	(b)	 	Subject to the adjustment provisions of Section 5.2, the
maximum number of shares of Common Stock which may be issued or
transferred to a participant subject to Stock Options in any single
year shall not exceed 100,000.
	 
	 	(c)	 	Notwithstanding anything in the Plan to the contrary, the
aggregate Market Value (determined on the date the Option is
granted) of the Common Stock for which any Key Employee may be
granted Incentive Stock Options in the calendar year in which such
Options are first exercisable (under all plans of the Company or any
Subsidiary which provide for the granting of Incentive Stock
Options) shall not exceed $100,000. Consultants may not be granted
Incentive Stock Options.
	 
	 	6.2.	 	Option Provisions. Options shall be subject to the following
provisions:
	 
	 	(a)	 	Options may be granted only to Key Employees and Consultants
selected by the Committee.
	 
	 	(b)	 	The Option price per share of Common Stock shall be
determined by the Committee, but shall not be less than 100% of the
Market Value thereof on the date the Option is granted.
	 
	 	(c)	 	The expiration date of each Option shall be established by
the Committee at the time the Option is granted, but such date shall
not be later than 10 years from the date the Option is granted.
Except as required with respect to Incentive Stock Options under
Section 422 of the Internal Revenue Code of 1986, as amended, the
Committee may extend the term of an Option which has a term of less
than 10 years for a period ending not later than 10 years from the
date of the Option grant and such extension shall not be deemed the
grant of a new or additional Option
for any purpose under the Plan or otherwise. The extension of the
term of an

5

 

	 	 	 	Option shall be subject to the consent of the holder of
the Option and may be made at any time prior to the expiration of
the Option. Incentive Stock Options may not be granted more than
10 years after the Plan is adopted by the stockholders of the
Company.
	 
	 	(d)	 	Options may be exercised as to all or any portion of the shares of
Common Stock subject to the Option while the original Optionee has
a relationship with the Company which confers eligibility to be
granted Options, but not later than the expiration date specified
in such Option.
	 
	 	(e)	 	Options granted to a Key Employee shall not be affected by
any change in the nature of the Key Employee’s employment so long as
he continues to be employed by the Company or a Subsidiary.
Approved leaves of absence shall not be considered a termination or
interruption of full-time employment for any purpose of the Plan.
	 
	 	(f)	 	Each Option shall terminate if and when the Optionee shall
cease to be an employee of or advisor or consultant to the Company
or its Subsidiaries, except as follows (subject to the provisions of
the Internal Revenue Code and applicable regulations of the U.S.
Treasury Department concerning Incentive Stock Options):

	 	(i)	 	If an Optionee dies while an employee of the
Company or a Subsidiary, his Option may be exercised to the
extent that the Optionee could have done so at the date of his
death by his Beneficiary, at any time, or from time to time,
within one year after the date of the Optionee’s death but not
later than the expiration date specified in such Option.
	 
	 	(ii)	 	If an Optionee’s employment by the Company or a
Subsidiary shall terminate because of Permanent Disability,
such employee may exercise his Option, to the extent that he
could have done so at the date of his termination of
employment, at any time, or from time to time, within one year
of such termination but not later than the expiration date
specified in such Option.
	 
	 	(iii)	 	If an Optionee’s employment by the Company or a
Subsidiary shall terminate due to Retirement, the Optionee may
exercise any Option to the extent that he could have done so
at the date of his termination of employment, at any time, or
from time to time, within one year of such Retirement (three
months in the case of an Incentive Stock Option) but not later
than the expiration date specified in such Option.
	 
	 	(iv)	 	Except as provided in the following provisions of
this Section 6.2(f), if the Optionee’s employment by the
Company or a Subsidiary shall terminate for any reason other
than death, Permanent Disability or Retirement, he may exercise his Option, to the extent that he could have
done so at the 

6

 

	 	 	 	date of his termination of employment, at any
time, or from time to time, within three months of the date
of termination of his employment but not later than the
expiration date specified in such Option.
	 
	 	(v)	 	Notwithstanding anything in the Plan to the
contrary, if an Optionee’s employment is terminated for cause,
his ability to exercise such Option shall terminate on the
date of his termination of employment. For this purpose,
termination for “cause” shall include termination for reason
of (i) Optionee’s conviction for, or plea of nolo contendere
to, a felony, (ii) Optionee’s commission of an act involving
self-dealing, fraud or personal profit materially injurious to
the Company or a Subsidiary, (iii) Optionee’s commission of an
act of willful misconduct or gross negligence in the conduct
of his employment duties to the Company or a Subsidiary, (iv)
habitual absenteeism or tardiness on the part of Optionee with
respect to his employment with the Company or a Subsidiary,
(v) Optionee’s breach or violation of any material internal
policies or rules of the Company or a Subsidiary concerning
the purchase and sale of that entity’s common stock or other
securities by employees of the Company or a Subsidiary, and
(vi) Optionee’s breach of any material provision of any
written employment agreement between Optionee and the Company
or a Subsidiary. The Committee shall determine in its sole
discretion whether a termination was made for cause.
	 
	 	(vi)	 	Notwithstanding anything in the Plan to the
contrary, the Committee may at any time with the consent of a
majority of the disinterested directors of the Company’s Board
of Directors terminate an Option if it shall, in the
reasonable exercise of its judgment, find that the Optionee
has disclosed without the written consent of an authorized
officer of the Company, to any person not employed by or
engaged to render services to the Company or a Subsidiary, any
material confidential information of the Company or a
Subsidiary or has engaged in material competition with the
Company or any Subsidiary or in any activities otherwise
contrary to the best interests of the Company or a Subsidiary.
The right to exercise the Option has been granted, and the
compensation to be realized in the event of exercise has been
provided, upon the express understanding that the Optionee
shall refrain from engaging in any activities contrary to the
best interests of the Company.

	 	(g)	 	If any Optionee is not an employee of the Company or a
Subsidiary, but rather is a Consultant to the Company or a
Subsidiary, the following provisions shall apply as if the Optionee
were an employee of the Company or a Subsidiary:

	 	(i)	 	Section 6.2(f)(i) shall apply if the Consultant
relationship terminates because of the Optionee’s death.

7

 

	 	(ii)	 	Section 6.2(f)(ii) shall apply if the Consultant
relationship terminates because of the Optionee’s Permanent
Disability.
	 
	 	(iii)	 	Section 6.2(f)(iii) shall apply if the
Consultant relationship terminates because of the Optionee’s
retirement.
	 
	 	(iv)	 	Section 6.2(f)(iv) shall apply if the Consultant
relationship terminates for any other reason than the
Optionee’s death, Permanent Disability or retirement.
	 
	 	(v)	 	Notwithstanding paragraphs (f)(i) through
(f)(iv), above, Section 6.2(f)(v) shall apply if the
Consultant relationship is terminated by the Company or a
Subsidiary for cause.
	 
	 	(vi)	 	Section 6.2(f)(vi) shall apply as written.

	 	(h)	 	Subject to the provisions of Sections 6.2(c), (d), (e), (f)
and (g) and of the Option agreement pursuant to which an Option is
granted, Options may be exercised, in whole or in part, at any time
during the term of the Option.
	 
	 	(i)	 	An Option shall be considered exercised under the Plan on the
date written notice is mailed (postage prepaid) or delivered to the
Secretary of the Company advising of the exercise of a particular
Option and transmitting payment of the Option price for the shares
involved, but this provision shall not preclude exercise of an
Option by any other proper legal method.
	 
	 	(j)	 	Options are not transferable other than by will or by the
laws of descent and distribution, and during a participant’s
lifetime are exercisable only by the Optionee or by his or her
guardian or legal representative.
	 
	 	(k)	 	The Committee may place such conditions and restrictions on
the exercise of Options and on the transferability of shares of
Common Stock received upon exercise of an Option, in addition to
those contained herein, as it shall deem appropriate and, without
limiting the generality of the foregoing, may provide in the Option
grant that shares of Common Stock issued or transferred upon
exercise of the Option shall be shares of Restricted Stock subject
to forfeiture upon failure to comply with such conditions and
restrictions.
	 
	 	(l)	 	Following the death of a participant, and upon the request of
the Beneficiary, the Company may at its election, (i) at any time
while the Option may be exercised, purchase the Option at a price
equal to the difference between the Market Value, on the date such
request is mailed (postage prepaid) or delivered to the Secretary of
the Company, of the shares of Common Stock subject to exercise and
the Option price of such shares of Common Stock, or (ii) within
thirty days following the exercise of an Option, purchase the shares
of Common Stock so acquired at their Market Value on the date of
exercise. The number of shares of Common Stock purchased by the
Company shall be considered issued and transferred for purposes of
Sections 5.1 and 6.2(c).

8

 

	 	(m)	 	No shares of Common Stock shall be issued or transferred upon
exercise of an Option until full payment therefor has been made.
Such payment shall be made in cash. A holder of an Option shall
have none of the rights of a stockholder until shares of Common
Stock are issued or transferred as the result of the exercise of
such Option. The proceeds received by the Company from the sale of
Common Stock pursuant to the Plan shall be available for general
corporate purposes.

7. General Provisions

     7.1. Neither the adoption of the Plan nor its operation, nor any booklet
or other document describing or referring to the Plan, or any part thereof, (a)
shall confer upon any employee any right to continue in the employ of the
Company or any Subsidiary or shall in any way affect the right and power of the
Company or any Subsidiary to dismiss or otherwise terminate the employment of
any employee at any time for any reason with or without cause, or (b) shall
confer upon any advisor or consultant to the Company or any Subsidiary any
right to continue in such capacity or shall in any way affect the right of the
Company to terminate the advisory or consulting relationship at any time for
any reason with or without cause. If the Company or any Subsidiary shall
terminate the employment or advisory or consulting relationship of a
participant for any reason, whether or not for cause, neither the Company nor
such Subsidiary shall incur any liability to the participant due to the
inability of the participant by reason of such termination to exercise
thereafter any Option, to receive any grant under the Plan or to be eligible
thereafter for any grant under the Plan.

     7.2. By accepting any benefits under the Plan, each participant and each
person claiming under or through him shall be conclusively deemed to have
indicated his acceptance and ratification of, and consent to, all provisions of
the Plan and any action or decision under the Plan by the Company, the Board of
Directors or the Committee.

     7.3. Appropriate provision shall be made for all taxes which the Company
requires to be withheld in connection with the exercise of Options, under the
laws of any governmental authority, whether Federal, state or local and whether
domestic or foreign. The Committee may in its discretion permit a participant
to elect at any time, but in no event later than six months prior to the
exercise of any Option, to have a portion of the shares subject to such
exercise withheld by the Company for the purpose of satisfying any tax
withholding under Federal, state or local tax laws.

     7.4. No rights under the Plan shall be assignable, either voluntarily
(except as may specifically be permitted for gifts of Restricted Stock), or
involuntarily by way of encumbrance, pledge, attachment, levy or charge of any
nature (except as may be required by state or federal law). Notwithstanding
anything in the Plan to the contrary, a participant may designate a Beneficiary
to receive an Option in the event of the participant’s death.

9

 

     7.5. Nothing in the Plan shall require the Company or any Subsidiary to
segregate or set aside any funds or other property for the purpose of paying
Common Stock upon the exercise of Options. No participant, Beneficiary or
other person shall have any right, title or interest in any amount awarded
under the Plan prior to payment thereof, or in any property of the Company or
its Subsidiaries or affiliated corporations.

     7.6. It is contemplated that the Company, although under no legal
obligation to do so, may from time to time purchase shares of Common Stock for
the purpose of paying an Option, or for the purpose of replacing shares issued
or transferred in payment of an Option. All shares so purchased shall, unless
and until transferred in payment of such Option, be at all times the property
of the Company available for any corporate purpose, and no participant or
employee or Beneficiary, individually or as a group, shall have any right,
title or interest in any shares of Common Stock so purchased.

     7.7. Headings are given to the sections of the Plan solely as a
convenience to facilitate reference; neither such headings nor numbering or
paragraphing shall be deemed in any way material or relevant to the
construction of the Plan or any provision thereof.

     7.8. The use of the masculine gender shall also include within its meaning
the feminine. The use of the singular shall include within its meaning the
plural and vice versa.

8. Compliance with Other Laws and Regulations

     The Plan, the grant and exercise of Options thereunder, and the obligation
of the Company to sell and deliver shares of Common Stock under such Options,
shall be subject to all applicable federal and state laws, rules and
regulations and to such approvals by any government or regulatory agency as may
be required. If at any time the Committee shall determine in its discretion
that the listing, registration or qualification of the shares covered by the
Plan upon any national securities exchange or under any state or federal law,
or the consent or approval of any government regulatory body, is necessary or
desirable as a condition of, or in connection with, the sale or purchase of
shares under the Plan, no shares will be delivered unless and until such
listing, registration, qualification, consent or approval shall have been
effected or obtained, or otherwise provided for, free of any conditions not
acceptable to the Committee. If shares are not required to be registered, but
are exempt from registration, upon exercising all or any portion of an Option,
the Company may require each Optionee (or any person acting under Section
6.2(f)(i)), to represent that the shares are being acquired for investment only
and not with a view to their sale or distribution, and to make such other
representations deemed appropriate by counsel to the Company. Stock
certificates evidencing unregistered shares acquired upon exercise of Options
shall bear any legend required by applicable state securities laws and a
restrictive legend substantially as follows:

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE
SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED IN THE
ABSENCE OF SUCH REGISTRATION OR AN OPINION OF COUNSEL ACCEPTABLE
TO THE COMPANY THAT SUCH TRANSFER WILL NOT REQUIRE REGISTRATION UNDER
SUCH ACT OR UNDER THE SECURITIES LAWS OF ANY STATE.

10

 

9. Effective Date

     The Plan shall become effective if and when, but not until, it is approved
by the stockholders of the Company.

10. Amendment or Termination of Program

     10.1. The Board of Directors may at any time and from time to time modify,
revise or amend the Plan in such respects as the Board of Directors may deem
advisable in order that the Options granted hereunder may conform to any
changes in the law or in any other respect that the Board of Directors may deem
to be in the best interests of the Company; provided, however, that without
approval by the stockholders of the Company voting the proper percentage of its
voting power, no such amendment shall make any change in the Plan for which
stockholder approval is required in order to comply with (i) Rule 16b-3, (ii)
the Internal Revenue Code of 1986, as amended, or regulatory provisions dealing
with Incentive Stock Options, (iii) any rules for listed companies promulgated
by any national stock exchange on which the Company’s Common Stock is traded or
(iv) any other applicable rule or law. All Options granted under the Plan
shall be subject to the terms and provisions of the Plan and any amendment,
modification or revision of the Plan shall be deemed to amend, modify or revise
all Options outstanding under the Plan at the time of the amendment,
modification or revision.

     10.2. The Board of Directors may, by resolution adopted by a majority of
the entire Board of Directors, at any time terminate the Plan or any portion
thereof.

     10.3. No amendment or termination of the Plan or any portion thereof by
the Board of Directors or the stockholders shall, without the consent of a
participant, adversely affect any award previously made or any Option or any
other rights previously granted to him.

11. Applicable Law

     This Plan and all rights hereunder shall be governed, construed and
administered in accordance with the laws of the State of Texas.

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00061-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00061-of-00352.parquet"}]]